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A coeliakia típusos formájában jellegzetes klinikai tünetekkel
járó, a gabonafélék gliadintartalmával szemben kialakuló
krónikus immun enteropathia, amely gyakran társul más
autoimmun mechanizmusú kórképekkel. Atípusos megje-
lenése esetén klasszikus tünetei hiányozhatnak vagy enyhék,
és az extraintestinalis tünetek vagy a társult szindrómák áll-
nak a klinikai kép elôterében. A szerzôk ilyen eset hosszmet-
szeti követését mutatják be. A most 63 éves nôbetegnek 19
éves korában kórismézték epilepsziáját, 36 éves korában
elôbb cerebellaris atrophiára, majd stiff-person-szindrómára
visszavezetett, progrediáló végtagataxiáját. Ötvenkilenc éves
korában, 2-es típusú diabetes fenotípusával manifesztáló-
dott, GAD-pozitivitás alapján utóbb 1-es típusúként reklasz -
szifikált cukorbetegsége. Csak a legutóbbi kivizsgálás derített
fényt a coeliakiára, amivel retrospektíve a teljes kórlefolyás,
neurológiai tünetei is magyarázhatóvá váltak. Az eset bemu-
tatásával a szerzôk arra hívják fel a figyelmet, hogy cerebel-
laris ataxia, progrediáló neurológiai tünetek és diabetes tár-
sulása esetén érdemes gondolni coeliakia lehetôségére. Az
idôben történô kórismézés ugyanis segíthet a folyamat
lassításában, eredményesebb kezelésében.
Kulcsszavak: 1-es típusú diabetes, coeliakia, 
stiff man/person szindróma, epilepsia, cerebellaris ataxia,
differenciáldiagnosztika
Celiac disease – in its typical form – is a chronic immune-
mediated enteropathy with typical clinical symptoms that
develops against gliadin content of cereal grains, and is
often associated with other autoimmune diseases. In cases
of atypical manifestation classic symptoms may be absent or
mild, and extra-intestinal symptoms or associated syn-
dromes dominate clinical picture. The authors present a lon-
gitudinal follow-up of such a case. A 63-years old woman
was diagnosed with epilepsy at the age of 19, and with pro-
gressive limb ataxia at the age of 36, which was initially
thought to be caused by cerebellar atrophy, later probably
by stiff person syndrome. At the age 59, her diabetes melli-
tus manifested with type 2 diabetic phenotype, but based on
GAD positivity later was reclassified as type 1 diabetes. Only
the last check-up discovered the celiac disease, retrospec-
tively explaining the entire disease course and neurological
symptoms. By presenting this case, the authors would like to
draw attention to the fact that one should think of the possi-
bility of celiac disease when cerebellar ataxia, progressive
neurological symptoms and diabetes are present at the
same time. An early diagnosis may help to delay the pro-
gression of disease and help better treatment.
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Type 1 diabetes mellitus (T1DM) is often associ-ated with other autoimmune conditions includ-
ing celiac disease (CD), also called gluten-sensitive
enteropathy. Celiac disease has a prevalence of
0.97–16.4% in children1, 2, and 2–5% in adults with
T1DM, depending on the method of detection
used3. Based on epidemiologic observations, its
prevalence has been increasing4. It is easily diag-
nosed when the classic signs of celiac disease post-
prandial diarrhoea, flatulence and weight loss are
present, however, these symptoms are often absent
in adults, and extra-intestinal, mainly neurological
symptoms, anaemia, infertility, osteopenia and dis-
turbance of carbohydrate metabolism dominate the
clinical picture3, 4. Gluten sensitivity (GS), not dam-
aging the intestinal villi is not identical with the
above mentioned entity, abdominal signs and symp-
toms are also absent, only extra-intestinal symptoms
draw attention of the clinician. In rare cases, both
conditions may be associated with neurological
signs, sometimes even dominating the clinical pres-
entation5.
A case history of a female patients is presented
to demonstrate: the combination of different neuro-
logic conditions lasting several decades associated
later with latent autoimmune type diabetes (LADA)
could be consistent with CD, recognised unfortu-
nately with an important delay. 
Case report 
The 69 years old female was transferred to our
department because of elevated blood sugar. She
was diagnosed with epilepsy with typical grand mal
(GM) seizures and temporal spikes on her EEG at
age 19: she was treated by phenytoin for years. She
was 36 when she first noticed a clumsiness of her
left leg. Neurological investigations suggested cere-
bellar atrophy due to phenytoin toxicity as a possi-
ble cause of the progressive limb ataxia. The drug
was withdrawn, and replaced by carbamazepine to
treat the recurrent seizures.
Shortly thereafter a periodic painful stiffness
manifested in the left leg, then the trunk muscles,
and her speech became scanning. Stiff person’s syn-
drome was hypothetized based on severe muscle
spasticity and exertional tachycardia. This assump-
tion was supported by the EMG finding and serum
glutaminic acid decarboxylase (GAD) antibodies.
Since the age of 53 she has been unable to walk and
she had to use wheelchair. Since the menopause –
appearing at age 54 – she had not seizures any more,
even without any antiepileptic medication.
The patient’s diabetes was revealed at age 59 in
an other institute. Because the GAD antibody result
was unknown there, type 2 diabetes was assumed
and treated with diet and combined oral antidiabet-
ic therapy, buformin and gliclazide. The patient was
seen in our department 4 years later, at the age 63,
and because of bad glycaemic control she was
switched to insulin. Based on the relatively rapidly
developing secondary sulfanylurea resistance, the
nutritional status (BMI: 17.8 kg/m2) and the now
presented GAD antibody finding (163 IU/ml,
ELISA kit, Euroimmun AG), the type of diabetes
was reclassified and LADA was diagnosed.
Awkwardness of her both legs and truncal ataxia
were already present wih scanning speech and spas-
tic paraparesis. Abdominal complaints (diarrhoea,
flatulence, distension) were negligible so in the past
as in the present. The emaciation and the evaluation
of the case history raised the possibility of CD. The
assumption was confirmed by a positive endomysi-
um antibody (EMA) finding (EMA IgG>1:64,
selective IgA deficiency). Subsequent duo-
denoscopy and biopsy also justified the diagnosis:
mild-moderate villous atrophy could be detected
(Figure 1.). The cranial CT showed frontal and
cerebellar atrophy. The confirmation of CD and
LADA raised the possibility that the uncommon
sequence of her neurological deficits might also be
associated with gluten sensitivity. A gluten-free diet
was introduced and an outpatient follow up of the
patient was decided. Although she seemed to be
cooperative at the beginning, in fact she was lost for
several years.
She was admitted to our department at the age
69 again, because her elevated blood sugar levels
could not be satisfactorily managed at home. The
HbA1c value was 9.9%, therefore the insulin dose
was modified. Laboratory tests showed serum C-
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peptide levels below the normal (>0.1 ng/mL), folic
acid (18.3 nmol/L) and B12 (332 pmol/L) levels
were within normal range. In addition to selective
IgA deficiency, IgG type anti-transglutaminase lev-
els of >400 mikromol/ml were detected indicating
that the patient has not kept a strict gluten-free diet,
possibly explaining her progressive neurological
symptoms.
A neurological assessment was performed again
showing dysarthria, scanning speech, severe spastic
paraparesis. Not only truncal and limb ataxia were
present but the clumsiness of her arms, too. The
EEG detected moderate, diffuse cortical dysfunc-
tion without epileptiform signs. Investigations for
peripheral sensory neuropathy revealed a mild
small fiber damage. HLA determination was per-
formed, the presence of DQ2.2 allel was found by
the patient (DQA1*02:01, DQB1*0202), which in
not typical in CD. The presence of one allel of the
DQ2 heterodimer (DQ2.x) is seen very rarely6, but
not unknown. Nevertheless she was carrying
HLAB1*07, too, which also corralates to CD.
With the modified insulin treatment, keeping a
strict gluten-free diet the patient became free from
complaints. At outpatient control one month later
her medical check-up showed stable state corres-
ponding the underlying disease.
Discussion
CD is a chronic, immune-mediated, inflammatory
disease in patients with genetic predisposition. It is
based on a T-cell mediated immune response
against gliadin proteins of cereal grains, such as
wheat, barley, rye, and oats. If the disease –  in its
typical form –  arises with malabsorption, inflam-
mation is seen at the proximal part of the small
intestine with destruction of the brush border and
the intestinal villi. However, classic symptoms –
diarrhoea, weight loss – may be absent. Atypical
manifestations are often seen in adult-onset cases7,
where intestinal symptoms are mild or absent and
extra-intestinal symptoms (anaemia, osteoporosis,
growth retardation, infertility, hepatopathia) domi-
nate. Some diseases frequently associate with CD,
e.g. enteropathy assocated T-cell lymphoma, type 1
diabetes mellitus, autoimmun thyreoiditis, dermati-
tis herpetiformis During, some neurological disea-
ses: epilepsy, cerebellar ataxia, neuropathy.
The diagnosis of CD is primarily based on sero-
logical investigations: elevated anti-tTG and EMA
levels are typical, both, their sensitivity and speci-
ficity are over 90%. In doubtful cases, biopsy of the
small intestine can confirm the diagnosis. The
measurement of anti-gliadin antibodies (AGA) per-
formed routinely earlier, has recently lost its signif-
icance because of low sensitivity and specificity (75
vs. 80%). In the latent form of the disease serologi-
cal findings – anti-tTG, EMA – are positive, how-
ever, biopsy of small intestine shows only minimal
changes. Patients with this form of the disease
should also be considered to have celiac disease,
and usual dietary restrictions should be introduced
because exacerbations may occur at any time.
Gluten sensitivity7, 8 (GS) is considered to be a
different entity from CD. These patients have sensi-
tivity to gliadin (mainly to wheat gluten). After
ingestion of food containing gliadin abdominal dis-
comfort and flatulence may occur, but without true
enteropathy and damage to the brush border and
intestinal villi. It is much more common than CD,
affecting 6-10% of the population. It is more diffi-
cult to diagnose, because anti-tTG and EMA levels
are normal, only IgA or IgG type AGA titres are
elevated. The latter finding is often misleading, as
AGA can be elevated in 10–20% of the population,
even without GS. This condition can only be firmly
diagnosed during follow-up, based on AGA posi-
tivity and elimination of complaints by a gluten-free
diet.
In 6–10% of patients with celiac disease neuro-
logical symptoms emerge, most often cerebellar
ataxia, polyneuropathy, epilepsy and later demen-
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Figure 1. Duodenal mucosa, partial villous atrophy,
PBA II (HE, 600×). The ration of villi/crypts 1/1, the villi
are shortened, widened, the number of the intraepithe-
lial lymphocytes reaches >50. Mild chronic inflammato-
ry cell infiltration in tunica propria of mucosa is seen,
with widened capillaries
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tia7–10. Only 1/3 of those with neurological symp-
toms have a diagnosis of CD, most of them have
only GS without enteropathy5.
The exact mechanism of the development of
neurological symptoms is still unclear. In the past,
vitamin-B1, -B12 and -E deficiency was proposed
based on malabsorption10, but other investigations
did not confirm low serum vitamin levels, and the
above neurological symptoms were also observed
in patients without biopsy-proven villous atrophy5,
11. In post mortem examinations perivascular
inflammation could be observed in the central nerv-
ous sytem and peripheral nerves12, while other
observations found the loss of cerebellar Purkinje-
cells13. It has been suggested that anti-gliadin anti-
bodies are neurotoxic, initiating an autoimmune
inflammatory process in the nervous tissue14.
Gluten ataxia may improve with introduction of
gluten-free diet, but clinical response depends on
the duration of ataxia15, and is inversely related to
the extent of irreversible loss of cerebellar Purkinje-
cells.
One of the most reputed experts of gluten ataxia,
Hadjivassiliou also described that mainly anti-TG2
levels increase when gastrointestinal symptoms are
present, and anti-TG615 levels are higher when neu-
rological symptoms are present. The latter can be
observed in GS, e.g. without villous atrophy, too.
These tests are not yet available in Hungary. While
in CD, HLADQ2 and/or DQ8 are carried in almost
100% of patients6, it was observed only in 80% of
cases with GS, and HLA-DQ1 carriage in the
remaining 20%5.
For the sake of completeness, it is worth men-
tioning that although serological findings normal-
ize a few months after introducing gluten-free diet,
it may happen in about 1% of cases16 that CD does
not improve. (The monitoring of anti-tTG and EMA
levels is also an efficient method to control diet and
patient compliance. Lack of or insufficient decrease
of levels may indicate dietary inaccuracies.)
The neurological symptoms of our patient had
begun before diagnosis of CD. Her cerebellar atax-
ia was initially ascribed to the adverse effect of
phenytoin, however, her gait instability did not
improve, even progressed after long-term with-
drawal of the drug. The main features of the subse-
quently proposed stiff person syndrome (SPS) are
rigidity and spasticity, affecting mainly the trunk
and the left leg muscles. The present of the anti-
GAD antibody could refer to SPS, epilepsy or cere-
bellar ataxia on the basis of literature17, 18. SPS is
often associated with T1DM, and anti-GAD anti-
bodies are often detected in both conditions19.
According to the literature avaible20 ataxia may be
associated to SPS in some cases. Moreover
Hadjivassiliou states that anti-GAD positive SPS
and gluten sensitivity are overlapping entities21.
Absence of the degenerative cerebellar disease in
her family history is inconsistent with the diagnosis
of spinocerebellar ataxia; the early onset of her neu-
rological symptoms, the absent of autonomic dys-
function and parkinsonism reduce the probability
of multiple system atrophy (cerebellar subtype).
Based on the entire history we can state that the
probability of the gluten ataxia and associated SPS
is fairly high in the background of her neurological
symptoms, even the epilepsy in her young ages
could be the first sign of CD in retrospective. She
had atypical CD, therefore, unfortunately, serologi-
cal examinations of diagnostic value were initially
not performed. Interestingly, her anti-GAD anti-
body positivity was forgotten during treatments,
explaining the fact that her diabetes was diagnosed
as T2DM, and treated with oral antidiabetics. The
compliance of our patient as she has also admitted
– was initially inappropriate: she kept only loosely
to the recommended gluten-free diet, which also
explains the temporary worsening of the neurologi-
cal symptoms. Gluten-free diet can improve her
neurological symptoms in the future and so could
give an ultimate proof of gluten ataxia, too.
With the presented case history we wanted to
draw attention to a possible, but often overlooked
comorbidity of T1DM, the development of CD and
GS. In case of cerebellar ataxia and progressive
neurological symptoms, one should think of a
causal relationship of abnormal findings, and per-
form comprehensive investigations to confirm or
rule out their association.
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